272 related articles for article (PubMed ID: 1505479)
1. Effect of human recombinant mullerian inhibiting substance on isolated epithelial and mesenchymal cells during mullerian duct regression in the rat.
Tsuji M; Shima H; Yonemura CY; Brody J; Donahoe PK; Cunha GR
Endocrinology; 1992 Sep; 131(3):1481-8. PubMed ID: 1505479
[TBL] [Abstract][Full Text] [Related]
2. Müllerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Müllerian duct regression.
Zhan Y; Fujino A; MacLaughlin DT; Manganaro TF; Szotek PP; Arango NA; Teixeira J; Donahoe PK
Development; 2006 Jun; 133(12):2359-69. PubMed ID: 16687449
[TBL] [Abstract][Full Text] [Related]
3. Androgen stimulation of nucleotide pyrophosphatase during mullerian duct regression.
Fallat ME; Hutson JM; Budzik GP; Donahoe PK
Endocrinology; 1984 May; 114(5):1592-8. PubMed ID: 6143657
[TBL] [Abstract][Full Text] [Related]
4. Mullerian duct regression and antiproliferative bioactivities of mullerian inhibiting substance reside in its carboxy-terminal domain.
MacLaughlin DT; Hudson PL; Graciano AL; Kenneally MK; Ragin RC; Manganaro TF; Donahoe PK
Endocrinology; 1992 Jul; 131(1):291-6. PubMed ID: 1612008
[TBL] [Abstract][Full Text] [Related]
5. Insensitivity of the chick embryo müllerian duct to human recombinant müllerian-inhibiting substance.
Weniger JP; Cate RL; Zeis A
J Mol Endocrinol; 1992 Feb; 8(1):73-7. PubMed ID: 1543536
[TBL] [Abstract][Full Text] [Related]
6. Cellular localization of müllerian inhibiting substance in the developing rat ovary.
Ueno S; Takahashi M; Manganaro TF; Ragin RC; Donahoe PK
Endocrinology; 1989 Feb; 124(2):1000-6. PubMed ID: 2643506
[TBL] [Abstract][Full Text] [Related]
7. Induction of WNT inhibitory factor 1 expression by Müllerian inhibiting substance/antiMullerian hormone in the Müllerian duct mesenchyme is linked to Müllerian duct regression.
Park JH; Tanaka Y; Arango NA; Zhang L; Benedict LA; Roh MI; Donahoe PK; Teixeira JM
Dev Biol; 2014 Feb; 386(1):227-36. PubMed ID: 24362065
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific fetal lung development and müllerian inhibiting substance.
Catlin EA; Powell SM; Manganaro TF; Hudson PL; Ragin RC; Epstein J; Donahoe PK
Am Rev Respir Dis; 1990 Feb; 141(2):466-70. PubMed ID: 2301861
[TBL] [Abstract][Full Text] [Related]
9. Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily.
Wilson CA; di Clemente N; Ehrenfels C; Pepinsky RB; Josso N; Vigier B; Cate RL
Mol Endocrinol; 1993 Feb; 7(2):247-57. PubMed ID: 8469238
[TBL] [Abstract][Full Text] [Related]
10. Paracrine-mediated apoptosis in reproductive tract development.
Roberts LM; Hirokawa Y; Nachtigal MW; Ingraham HA
Dev Biol; 1999 Apr; 208(1):110-22. PubMed ID: 10075845
[TBL] [Abstract][Full Text] [Related]
11. Involution of the female Mullerian duct of the fetal rat in the organ-culture assay for the detection of Mullerian Inhibiting Substance.
Price JM; Donahoe PK; Ito Y
Am J Anat; 1979 Oct; 156(2):265-84. PubMed ID: 506954
[TBL] [Abstract][Full Text] [Related]
12. The müllerian inhibitor and mammalian sexual development.
Behringer RR
Philos Trans R Soc Lond B Biol Sci; 1995 Nov; 350(1333):285-8; discussion 289. PubMed ID: 8570693
[TBL] [Abstract][Full Text] [Related]
13. [Antagonistic actions of testosterone and the anti-mullerian hormone on the mullerian duct of the chick embryo in culture in vitro].
Weniger JP; Zeis A
Arch Anat Microsc Morphol Exp; 1982; 71(2):99-106. PubMed ID: 6897160
[TBL] [Abstract][Full Text] [Related]
14. [Precocious production of müllerian inhibitor by the fetal rabbit testis].
Koike S; Jost A
C R Seances Acad Sci III; 1982 Dec; 295(12):701-5. PubMed ID: 6820303
[TBL] [Abstract][Full Text] [Related]
15. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
16. Cyclic adenosine 3',5'-monophosphate modulation of mullerian duct regression.
Ikawa H; Hutson JM; Budzik GP; Donahoe PK
Endocrinology; 1984 May; 114(5):1686-91. PubMed ID: 6201348
[TBL] [Abstract][Full Text] [Related]
17. Timing and irreversibility of Müllerian duct inhibition in the embryonic reproductive tract of the human male.
Taguchi O; Cunha GR; Lawrence WD; Robboy SJ
Dev Biol; 1984 Dec; 106(2):394-8. PubMed ID: 6548718
[TBL] [Abstract][Full Text] [Related]
18. Müllerian inhibiting substance inhibits branching morphogenesis and induces apoptosis in fetal rat lung.
Catlin EA; Tonnu VC; Ebb RG; Pacheco BA; Manganaro TF; Ezzell RM; Donahoe PK; Teixeira J
Endocrinology; 1997 Feb; 138(2):790-6. PubMed ID: 9003016
[TBL] [Abstract][Full Text] [Related]
19. Human recombinant mullerian inhibiting substance inhibition of rat oocyte meiosis is reversed by epidermal growth factor in vitro.
Ueno S; Manganaro TF; Donahoe PK
Endocrinology; 1988 Sep; 123(3):1652-9. PubMed ID: 2456917
[TBL] [Abstract][Full Text] [Related]
20. Zinc chelation and mullerian duct regression.
Schwartz BR; Trelstad RL; Hutson JM; Ikawa H; Donahoe PK
J Exp Pathol; 1984; 1(2):143-56. PubMed ID: 6443794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]